Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 185

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 185
---
 (3)                               1,762,585      1,606,147      39.46      87.10  
  CGY Investments Limited (4)                                      533,575        -              7.47       0.29   
  L1 Capital Global Opportunities Master Fund, Ltd.                383,750        -              5.37       0.21   

  Less than 1% of total outstanding Ordinary Shares on an as converted basis.  

  (1)      For each person and group included in this column, percentage ownership is calculated by dividing the number of Class A Ordinary Shares and Class B Ordinary Shares beneficially owned by such pe...  

  (2)      For each person and group included in this column, percentage of total voting power represents voting power based on both Class A Ordinary Shares and Class B Ordinary Shares beneficially owned ...  

  (3)      Includes 370,308 Class A Ordinary Shares owned by Jurchen, warrants held by Jurchen to purchase 54,054 Class A Ordinary Shares, convertible notes held by Jurchen to convert 1,338,223 Class A Or...  

  (4)      CGY Investments Limited is 50% held by Seng Fun Yee, 25% held by Mandy Lui and 25% held by Adrian Lui (all of whom are related to our former CEO, Mr. Darren Lui). Mr. Lui controls and/or has su...  

F. Disclosure of a registrant’s action
to recover erroneously awarded compensation.

None.

Item 7. MAJOR SHAREHOLDERS AND RELATED PARTY
TRANSACTIONS

A. Major Shareholders

Please refer to “ Item
6. Directors, Senior Management and Employees - E. Share Ownership.”

B. Related Party Transactions

Lines of Credit

On August 13, 2019 (the “ Effective Date”), Aptorum Therapeutics
Limited (“ ATL”), one of our wholly owned subsidiaries, entered into two separate Promissory Notes and Line of Credit Agreements
(the “ Agreements”) with Aeneas Group Limited and Jurchen Investment Corporation (“ Jurchen”). The Aeneas Group
Limited Agreement and Jurchen Agreement provide ATL with a line of credit up to twelve million dollars ($12,000,000) and three million
dollars ($3,000,000), respectively (collectively, the “ Line of Credit”), representing the maximum aggregate amount of the
advances